Projects per year
Personal profile
Education
- 2007-2013 Ph.D., The Institute of Basic Medical Sciences, National Cheng Kung University
- 2004-2006 M.S., Institute of Biomedical Research, National Sun Yat-sen University
- 2000-2004 B.S., Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University
Experience
- 2019.08- Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2015.03-2019.08 Postdoctoral Research Fellow, Molecular and Cell Biology, Baylor College of Medicine
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Study the Role of Annexin Protein in Collagen-Rich Tumor Microenvironment Modulates Anti-Tumor Drug Sensitivity of Bladder Tumor and Its Clinical Therapeutic Application
Lee, Y.-C. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
探討膀胱癌對第三代EGFR標靶藥物 AZD9291治療下產生抗藥性的可能機制
Lee, Y.-C. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
探討DDR1透過調控IL-1RA表現影響膀胱 癌進展的可能性
Lee, Y.-C. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
腫瘤微環境應答性之奈⽶複合材料之開發與癌症治療
Lee, Y.-C. (PI)
1/1/24 → 12/31/24
Project: C - Project of Alliance › m - National Taiwan University of Science and Technology
-
Study of Extracellular Matrix Collagens-Driven Acidic Microenvironment Confers Malignant Properties in Bladder Tumors (2/2)
Lee, Y.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor
Lai, G. Y., Lee, Y. C., Weng, H. J., Lai, K. H., Hsiang, M. C., Hsu, K. Y. & Liao, C. P., Dec 2025, In: Cell Death Discovery. 11, 1, 83.Research output: Contribution to journal › Article › peer-review
Open Access -
Hypoxia-Targeted-Therapy: Mussel-inspired hollow polydopamine nanocarrier containing MoS2 nanozyme and tirapazamine with anti-angiogenesis property for synergistic tumor therapy
Demissie, G. G., Chen, Y. C., Ciou, S. Y., Hsu, S. H., Wang, C. Y., Huang, C. C., Chang, H. T., Lee, Y. C. & Chang, J. Y., May 2025, In: Journal of Colloid and Interface Science. 685, p. 396-414 19 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17
Chan, Y. J., Hsiao, G., Wan, W. N., Yang, T. M., Tsai, C. H., Kang, J. J., Lee, Y. C., Fang, T. C., Cheng, Y. W. & Li, C. H., Dec 2023, In: Fluids and Barriers of the CNS. 20, 1, 31.Research output: Contribution to journal › Article › peer-review
Open Access7 Citations (Scopus) -
Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism
Lee, Y. C. & Chung, H. H., Mar 2023, In: British Journal of Clinical Pharmacology. 89, 3, p. 1222-1223 2 p.Research output: Contribution to journal › Letter › peer-review
-
Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
Lee, Y. C., Lin, C. H., Chang, W. L., Lin, W. D., Pan, J. K., Wang, W. J., Su, B. C., Chung, H. H., Tsai, C. H., Lin, F. C., Wang, W. C. & Lu, P. J., Apr 1 2022, In: International journal of molecular sciences. 23, 8, 4367.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)